CLDI.WS
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
CLDI.WS
Delisted
CLDI.WS was delisted on the 17th of October, 2024.
26 hedge funds and large institutions have $2.98M invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
26
Holding in Top 10
–
Calls
$4.88M
Puts
–
Top Buyers
| 1 | +$128K | |
| 2 | +$30K | |
| 3 | +$14.3K | |
| 4 |
EFI
EHP Funds Inc
Toronto,
Canada
|
+$5.04K |
| 5 |
CAC
Cowen and Company
New York
|
+$2.21K |
Top Sellers
| 1 | -$348K | |
| 2 | -$196K | |
| 3 | -$67K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$53K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$49.3K |